Drug 'reverses' ageing in animal tests

  • Thread starter Thread starter Greg Bernhardt
  • Start date Start date
  • Tags Tags
    Animal
Click For Summary

Discussion Overview

The discussion centers around a drug that reportedly reverses aspects of aging in animal tests, specifically in mice, and the implications for future human trials. Participants explore the potential for further testing, the challenges of translating animal research to humans, and the complexities of experimental design and funding in clinical trials.

Discussion Character

  • Exploratory
  • Technical explanation
  • Debate/contested
  • Meta-discussion

Main Points Raised

  • Some participants express interest in the drug's potential and inquire about future tests.
  • One participant highlights the evolutionary differences between mice and humans, suggesting that successful experiments on mice may not directly translate to human outcomes.
  • A participant discusses the challenges of conducting definitive randomized controlled trials (RCTs) due to high costs and the necessity of diverse participant pools.
  • Concerns are raised about the availability and commercialization of treatments derived from research, particularly regarding compounds that cannot be patented.
  • Another participant mentions the prevalence of minimally tested supplements in the market and the importance of resources like the NIH alternative medicine site for evaluating their validity.

Areas of Agreement / Disagreement

Participants generally agree on the potential of the drug and the need for further research, but there are competing views regarding the feasibility of translating animal research to human applications and the economic challenges of conducting large-scale clinical trials.

Contextual Notes

Limitations include the lack of definitive results from animal studies, the dependence on the design and funding of clinical trials, and the unresolved status of many supplements in the market.

Messages
19,910
Reaction score
10,919
A drug that can reverse aspects of ageing has been successfully trialled in animals, say scientists.

They have rejuvenated old mice to restore their stamina, coat of fur and even some organ function.

The team at Erasmus University Medical Center, in the Netherlands, are planning human trials for what they hope is a treatment for old age.

A UK scientist said the findings were "impossible to dismiss", but that unanswered questions remained.

http://www.bbc.com/news/health-39354628

Paper
http://www.cell.com/cell/fulltext/S0092-8674(17)30246-5
 
Biology news on Phys.org
Very interesting. Are there any further tests planned in the near future?
 
This describes a hypothetical animal that is the common ancestor of the placental mammals: http://www.livescience.com/26929-mama-first-ancestor-placental-mammals.html

If you are willing to accept that notion, then mice and humans have been evolving separately for about 64 million years. That is a big reason why successful experiments on mice do not always translate well to humans. Yes. They are planning more research. As a side note: failures are not usually published, so there is a reasonable chance you may never see more news reports on this line of investigation.
 
This thread deserves some explanation -not about Biology but about experimental design and
economics.

Bruce Ames at U Washington has done a lot of work on the mitochondrial theory of ageing.
Specifically, his group found that α-lipoic acid and L-acetyl carnitine given to rats did in fact
reverse some aspects of ageing - mostly relating to cognitive traits. So his group did
some human clinical research which had positive results. Nothing more definitive was done.
I'll define more definitive later.

Herein lies the problem - the kind of study that would establish the treatment as a bona fide
result would require so much expense that only a major pharmaceutical company or the
government can possibly pay for it. Those trials are called RCT - random contolled trial.
They are the definitive gold standard.

Clinical means study small group of volunteers usually for a few months at most. Some
cost for one physician's time and some supplies, with some administrative overhead to
oversee ethical and legal aspects.

RCT's require people all over the human genetic spectrum from all over the world, meaning
thousands of patients under medical care at facilities in many countries. The word
expensive does not do justice to this. Many medical facilities do nothing but run these
kinds of trials. Big business.

Anyway, since those two chemicals have been available for years, nobody can patent them.
It would be like trying to patent aspirin. So nobody can charge US$10.00 per pill to recoup
costs and pay off shareholders and bank loans. This whole thing is a big problem.

In the US there are too many minimally tested or untested supplements for sale. Labeling
restrictions are minimal as well. So if you google for one of the compound names listed,
you get lots of pill pushers' ads. This is essentially the fate of Bruce Ames research now.

Before someone points this out: https://nccih.nih.gov/ NIH alternative medicine site.
It is a great resource on known validity of supplements and too few people use to check supplements.

They do fund some limited studies on some supplements. Not all. But, IMO, there is still
a bunch of snake oil for sale out there.
 
Last edited:
  • Like
Likes   Reactions: berkeman

Similar threads

  • · Replies 9 ·
Replies
9
Views
3K
  • · Replies 4 ·
Replies
4
Views
4K
  • · Replies 1 ·
Replies
1
Views
12K